![](https://investorshub.advfn.com/uicon/1756.png?cb=1585521346)
Thursday, March 24, 2022 3:30:09 AM
On March 21, 2022, Diffusion Pharmaceuticals, Inc. (DFFN)
announced financial results for the fourth quarter and full year
2021 and provided a business update. The company intends to
develop its lead compound, trans sodium crocetinate (TSC), for
the treatment of hypoxic solid tumors. Diffusion will be filing a
study protocol with the U.S. FDA and we anticipate a trial
initiating in the second half of 2022, subject to FDA feedback and
the availability of study drug. In the interim, the company has
initiated two additional oxygenation trials – 1) the Altitude Trial is
investigating the consumption of oxygen in the presence of TSC
in a simulated high altitude environment; and 2) The ILD-DLCO
is a double-blind, randomized, placebo controlled study to
evaluate the effects of TSC on diffusion of carbon monoxide
through the lungs (DLCO) of patients with interstitial lung
disease. Results for the Altitude Trial should be available in mid2022, while results for the ILD-DLCO trial should be available in
the second half of 2022.
Recent DFFN News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/12/2024 08:06:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 08:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:28:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:27:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:23:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:22:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:21:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:20:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:19:15 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/14/2024 08:09:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:09:17 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/06/2024 10:03:11 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/06/2024 04:15:07 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/30/2024 09:18:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:07:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 09:06:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:06:16 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 09:09:15 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2024 08:06:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2024 12:00:12 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 04/11/2024 11:55:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/05/2024 08:06:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/04/2024 11:00:15 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/29/2024 08:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2024 12:36:06 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM